Physician profile
Mona K Gill
NPI 1477856003
$1,866.14
in general payments reported to CMS, 2019-2025
18 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.47 · 2020: $153 · 2021: $149 · 2022: $651 · 2023: $423 · 2024: $148 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $885 · Entertainment: $16.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.90 |
| Entertainment | $16.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $355.09 | 2022-2024 | Infuse, Miebo |
| Biotissue Holdings INC. | $343.90 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $204.10 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $137.74 | 2020-2021 | |
| Johnson & Johnson Vision Care, INC. | $136.95 | 2019-2024 | Acuvue |
| Lkc Technologies, INC. | $135.40 | 2025 | |
| Optos, INC. | $122.59 | 2022-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Allergan, INC. | $109.84 | 2021-2022 | |
| Sight Sciences, INC. | $90.65 | 2021-2022 | |
| Glaukos Corporation | $84.37 | 2023 | |
| Sun Pharmaceutical Industries INC. | $24.41 | 2023 | Cequa |
| Collegium Pharmaceutical, INC. | $20.14 | 2024 | Xtampza |
| Rxsight INC | $19.67 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Alcon Vision LLC | $18.00 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $17.43 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $17.13 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.39 | 2021 | |
| Kala Pharmaceuticals, INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.